Document
IPR2018-01714, No. 1006 Exhibit - Singhal et al, Antitumor Activity of Thalidomide in Refractory Multiple Myeloma, N Engl J Med, 3411565 1571 1999 (P.T.A.B. Sep. 12, 2018)
Cite Document
IPR2018-01714, No. 1006 Exhibit - Singhal et al, Antitumor Activity of Thalidomide in Refractory Multiple Myeloma, N Engl J Med, 3411565 1571 1999 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
IPR2018-01714, No. 1040 Exhibit - Weber, D, et al, Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America, N Engl J Med 357212133 2142 2007 (P.T.A.B. Sep. 12, 20...
Cite Document
IPR2018-01714, No. 1040 Exhibit - Weber, D, et al, Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America, N Engl J Med 357212133 2142 2007 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
IPR2018-01714, No. 1023 Exhibit - Koo et al, Vancomycin induced neutropenia, Drug Intell Clin Pharm, 2010780 782 1986 (P.T.A.B. Sep. 12, 2018)
Cite Document
IPR2018-01714, No. 1023 Exhibit - Koo et al, Vancomycin induced neutropenia, Drug Intell Clin Pharm, 2010780 782 1986 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
IPR2018-01714, No. 2009 Exhibit - Ex 2009 Marriott 2002 (P.T.A.B. Dec. 18, 2018)
Cite Document
IPR2018-01714, No. 2009 Exhibit - Ex 2009 Marriott 2002 (P.T.A.B. Dec. 18, 2018)
+ More Snippets
Document
IPR2018-01714, No. 1055-5 Exhibit - Declaration of James L Mullins, PhD Part 4 of 5 (P.T.A.B. Sep. 12, 2018)
Cite Document
IPR2018-01714, No. 1055-5 Exhibit - Declaration of James L Mullins, PhD Part 4 of 5 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
IPR2018-01714, No. 1055 Exhibit - Declaration of James L Mullins, PhD Part 1 of 5 (P.T.A.B. Sep. 12, 2018)
Cite Document
IPR2018-01714, No. 1055 Exhibit - Declaration of James L Mullins, PhD Part 1 of 5 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
IPR2018-01714, No. 2008 Exhibit - Ex 2008 File History Excerpt (P.T.A.B. Dec. 18, 2018)
Cite Document
IPR2018-01714, No. 2008 Exhibit - Ex 2008 File History Excerpt (P.T.A.B. Dec. 18, 2018)
+ More Snippets
Document
IPR2018-01714, No. 1019 Exhibit - Jacobs et al, Prednisone in MOPP chemotherapy for Hodgkins disease, Br Med J, 21469 1471 1976 (P.T.A.B. Sep. 12, 2018)
Cite Document
IPR2018-01714, No. 1019 Exhibit - Jacobs et al, Prednisone in MOPP chemotherapy for Hodgkins disease, Br Med J, 21469 1471 1976 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
IPR2018-01714, No. 1016 Exhibit - Hideshima, et al, Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy, Blood, 962943 2950 2000 (...
Cite Document
IPR2018-01714, No. 1016 Exhibit - Hideshima, et al, Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy, Blood, 962943 2950 2000 (P.T.A.B. Sep.
+ More Snippets
Document
IPR2018-01714, No. 1002 Exhibit - Prosecution History excerpts for US Patent No 7,968,569 (P.T.A.B. Sep. 12, 2018)
Cite Document
IPR2018-01714, No. 1002 Exhibit - Prosecution History excerpts for US Patent No 7,968,569 (P.T.A.B. Sep. 12, 2018)
+ More Snippets
Document
REVLIMID, 021880, Label (Orange Book Feb. 22, 2017)
Cite Document
REVLIMID, 021880, Label (Orange Book Feb. 22, 2017)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Feb. 22, 2017)
Cite Document
REVLIMID, 021880, Letter (Orange Book Feb. 22, 2017)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Apr. 22, 2016)
Cite Document
REVLIMID, 021880, Letter (Orange Book Apr. 22, 2016)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Dec. 1, 2015)
Cite Document
REVLIMID, 021880, Letter (Orange Book Dec. 1, 2015)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Oct. 27, 2015)
Cite Document
REVLIMID, 021880, Letter (Orange Book Oct. 27, 2015)
+ More Snippets